BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3604262)

  • 1. Identification of urinary and microsomal metabolites of geranylgeranylacetone in rats.
    Nishizawa Y; Abe S; Yamada K; Nakamura T; Yamatsu I; Kinoshita K
    Xenobiotica; 1987 May; 17(5):575-84. PubMed ID: 3604262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incorporation of radioactivity into amino acids and fatty acids after administration of 14C-geranylgeranylacetone to rats.
    Nishizawa Y; Tanaka H; Kinoshita K
    Xenobiotica; 1987 Apr; 17(4):469-76. PubMed ID: 3604254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum and stomach tissue levels of geranylgeranylacetone in patients.
    Nakazawa S; Tsuboi Y; Tsukamoto Y; Yoshino J; Okada M
    Int J Clin Pharmacol Ther Toxicol; 1983 Jun; 21(6):267-70. PubMed ID: 6885198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the pharmacokinetics and metabolism of 4-chlorodiphenyl ether in rats.
    Chui YC; Addison RF; Law FC
    Drug Metab Dispos; 1987; 15(1):44-50. PubMed ID: 2881758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liquid chromatography-mass spectrometry and gas chromatography-mass spectrometry of omega- and (omega-1)-hydroxylated metabolites of elaidic and oleic acids in human and rat liver microsomes.
    Adas F; Picart D; Berthou F; Simon B; Amet Y
    J Chromatogr B Biomed Sci Appl; 1998 Sep; 714(2):133-44. PubMed ID: 9766853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biotransformation of phenol to hydroquinone and catechol by rat liver microsomes.
    Sawahata T; Neal RA
    Mol Pharmacol; 1983 Mar; 23(2):453-60. PubMed ID: 6835203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the metabolism of l-menthol in rats.
    Madyastha KM; Srivatsan V
    Drug Metab Dispos; 1988; 16(5):765-72. PubMed ID: 2906604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidation of docosahexaenoic acid by rat liver microsomes.
    VanRollins M; Baker RC; Sprecher HW; Murphy RC
    J Biol Chem; 1984 May; 259(9):5776-83. PubMed ID: 6232277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism of CDRI-85/92, a new potent anti-ulcer agent, involving cis-trans conversion.
    Srivastava P; Sharma P; Lal J; Dikshit DK; Madhusudanan KP; Gupta RC
    Drug Metabol Drug Interact; 2004; 20(1-2):57-75. PubMed ID: 15283303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydroxylation of 4,4'-methylenebis(2-chloroaniline) by canine, guinea pig, and rat liver microsomes.
    Chen TH; Kuslikis BI; Braselton WE
    Drug Metab Dispos; 1989; 17(4):406-13. PubMed ID: 2571481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the biotransformation of ketamine. 1-Identification of metabolites produced in vitro from rat liver microsomal preparations.
    Adams JD; Baillie TA; Trevor AJ; Castagnoli N
    Biomed Mass Spectrom; 1981 Nov; 8(11):527-38. PubMed ID: 7317567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism of the thiocarbamate herbicide SUTAN in rats.
    Peffer RC; Campbell DD; Ritter JC
    Xenobiotica; 1991 Sep; 21(9):1139-52. PubMed ID: 1788982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biotransformation of felodipine in liver microsomes from rat, dog, and man.
    Bäärnhielm C; Backman A; Hoffmann KJ; Weidolf L
    Drug Metab Dispos; 1986; 14(5):613-8. PubMed ID: 2876870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and characterization of urinary metabolites of arbaprostil in the rat.
    Thornburgh BA; Shaw SR; Wickrema Sinha AJ
    Eur J Drug Metab Pharmacokinet; 1986; 11(1):61-9. PubMed ID: 3720796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Biotransformation and pharmacokinetics of grandiflorenic acid [kauradien-9(11),16-oic acid-18] / 2nd communication (author's transl)].
    Neidlein R; Stumpf U
    Arzneimittelforschung; 1977; 27(6):1162-6. PubMed ID: 578433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism of olaquindox in rat liver microsomes: structural elucidation of metabolites by high-performance liquid chromatography combined with ion trap/time-of-flight mass spectrometry.
    Liu Z; Huang L; Dai M; Chen D; Wang Y; Tao Y; Yuan Z
    Rapid Commun Mass Spectrom; 2008 Apr; 22(7):1009-16. PubMed ID: 18320546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of the biotransformation of the cardiotonic agent piroximone by high-performance liquid chromatography and gas chromatography-mass spectrometry.
    Berg-Candolfi M; Borlakoglu JT; Dulery B; Jehl F; Haegele KD
    J Chromatogr; 1992 Feb; 593(1-2):1-7. PubMed ID: 1639892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism of the hypolipidemic agent tiadenol in man and in the rat.
    Maffei Facino R; Carini M; Tofanetti O
    Arzneimittelforschung; 1986 Apr; 36(4):722-8. PubMed ID: 3718595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biotransformation of terodiline. II. Disposition in the male rat. Identification of metabolites in rat urine and rat liver microsomes by mass spectrometry.
    Norén B; Strömberg S; Ericsson O; Vangbo B; Grälls M; Widlund L; Lindeke B
    Acta Pharm Suec; 1985; 22(3):131-46. PubMed ID: 4036638
    [No Abstract]   [Full Text] [Related]  

  • 20. Geranylgeranylacetone protects against acetaminophen-induced hepatotoxicity by inducing heat shock protein 70.
    Nishida T; Matsura T; Nakada J; Togawa A; Kai M; Sumioka I; Minami Y; Inagaki Y; Ishibe Y; Ito H; Ohta Y; Yamada K
    Toxicology; 2006 Feb; 219(1-3):187-96. PubMed ID: 16377054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.